Author Mishra, Poonam
Florian, Jeffry
Ayala, Ruben
Amur, Shashi
Robertson, Sarah
Jadhav, Pravin R.
Pacanowski, Michael
Soon, Greg
O'Rear, Jules
Zeng, Wen
Harrington, Patrick
Murray, Jeffrey
Singer, Mary
Author_xml – sequence: 1
  givenname: Jeffry
  surname: Florian
  fullname: Florian, Jeffry
  email: Jeffry.Florian@fda.hhs.gov
– sequence: 2
  givenname: Pravin R.
  surname: Jadhav
  fullname: Jadhav, Pravin R.
– sequence: 3
  givenname: Shashi
  surname: Amur
  fullname: Amur, Shashi
– sequence: 4
  givenname: Ruben
  surname: Ayala
  fullname: Ayala, Ruben
– sequence: 5
  givenname: Patrick
  surname: Harrington
  fullname: Harrington, Patrick
– sequence: 6
  givenname: Poonam
  surname: Mishra
  fullname: Mishra, Poonam
– sequence: 7
  givenname: Jules
  surname: O'Rear
  fullname: O'Rear, Jules
– sequence: 8
  givenname: Michael
  surname: Pacanowski
  fullname: Pacanowski, Michael
– sequence: 9
  givenname: Sarah
  surname: Robertson
  fullname: Robertson, Sarah
– sequence: 10
  givenname: Mary
  surname: Singer
  fullname: Singer, Mary
– sequence: 11
  givenname: Greg
  surname: Soon
  fullname: Soon, Greg
– sequence: 12
  givenname: Wen
  surname: Zeng
  fullname: Zeng, Wen
– sequence: 13
  givenname: Jeffrey
  surname: Murray
  fullname: Murray, Jeffrey
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22610696$$D View this record in MEDLINE/PubMed
BookMark eNp90c1OFTEUB_DGYOSCLnwB08QNLgb6NTOtOyAIJiS6wPWk056B3sxtx7YDsnPvxjfxIXwTnsReLhpDoqumze9_0nPODtrywQNCLynZp4SwgyuY9lktBX-CFrRmbcV5TbbQgrCWVIpytY12UloSQpRg8hnaZqyhpFHNAn07CgamCNcuYhuS85d4CBGPOgOOkKbgLcSEtbfYz-P419tbfHFVTBgBhwH30dnLddrqrHEP-QbA4xxB5xX4fPf1u9c_f1zDfaVygy8TRAfegMVp7pdgcnqOng56TPDi4dxFn96dXByfVecfTt8fH55XhkvJK81ULUsDSvaCcVs3sq-VlIINsgWre6qsbhUYI4QlbU0Ma6kRyg5SWNtow3fR3qbuFMPnGVLuVi4ZGEftIcypo5yKlsgy2UJfP6LLMEdffrdWrVC8bZqiXj2ouV-B7aboVjredr_HXMCbDTAxpBRh-EMo6dYr7MoKu_sVFnvwyBqXdXbB56jd-L_EjRvh9t-lu7OTj5vELzpysFI
CODEN HPTLD9
CitedBy_id crossref_primary_10_1053_j_gastro_2014_10_027
crossref_primary_10_1053_j_gastro_2014_10_028
crossref_primary_10_1002_hep_27107
crossref_primary_10_3389_fphar_2023_1118771
crossref_primary_10_1007_s43441_022_00439_4
crossref_primary_10_1002_cpt_185
crossref_primary_10_1002_psp4_5
crossref_primary_10_1111_liv_12070
crossref_primary_10_1002_hep_27880
crossref_primary_10_1002_hep_26177
crossref_primary_10_1002_jps_23570
Cites_doi 10.1056/NEJMoa1010494
10.2165/11593210-000000000-00000
10.1128/AAC.00667-09
10.1056/NEJMoa0808010
10.1056/NEJMoa1009482
ContentType Journal Article
Copyright Copyright © 2012 American Association for the Study of Liver Diseases
Copyright_xml – notice: Copyright © 2012 American Association for the Study of Liver Diseases
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
DOI 10.1002/hep.25843
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 907
ExternalDocumentID 2920211291
22610696
10_1002_hep_25843
HEP25843
Genre article
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AANHP
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACLDA
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ABJNI
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3883-a295826198b423d568b598842f87edab19da79ecc44d0750c271c49df84dd6ac3
IEDL.DBID DR2
ISSN 0270-9139
1527-3350
IngestDate Thu Jul 10 22:53:00 EDT 2025
Fri Jul 25 22:56:14 EDT 2025
Thu Apr 03 07:04:43 EDT 2025
Thu Apr 24 22:54:44 EDT 2025
Tue Jul 01 03:33:32 EDT 2025
Wed Jan 22 16:23:36 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3883-a295826198b423d568b598842f87edab19da79ecc44d0750c271c49df84dd6ac3
Notes fax: (301)‐847‐8720
Disclaimer: the contents of the article represent the authors' personal opinion and do not necessarily reflect any position of the Food and Drug Administration.
Potential conflict of interest: Nothing to report.
Data for these analyses were submitted to the United States Food and Drug Administration by Merck as part of a new drug application.
See Editorial on Page 875
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.25843
PMID 22610696
PQID 1317493766
PQPubID 996352
PageCount 5
ParticipantIDs proquest_miscellaneous_1314708002
proquest_journals_1317493766
pubmed_primary_22610696
crossref_primary_10_1002_hep_25843
crossref_citationtrail_10_1002_hep_25843
wiley_primary_10_1002_hep_25843_HEP25843
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2013
2013-03-00
2013-Mar
20130301
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: March 2013
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2013
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wolters Kluwer Health, Inc
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wolters Kluwer Health, Inc
References 2011
2010; 54
201131; 364
2011; 364
2009; 361
2011; 50
Poordad (R2-10-20241201) 201131; 364
Lee (R8-10-20241201) 2011; 50
Bacon (R3-10-20241201) 2011; 364
Li (R7-10-20241201) 2010; 54
McHutchison (R11-10-20241201) 2009; 361
23456679 - Hepatology. 2013 Mar;57(3):875-7
References_xml – year: 2011
– volume: 54
  start-page: 375
  year: 2010
  end-page: 379
  article-title: Pharmacometrics‐based dose selection of levofloxacin as a treatment for postexposure inhalation anthrax in children
  publication-title: Antimicrob Agents Chemother
– article-title: Interferon responsiveness does not change in experienced hepatitis C subjects: implications for drug development and clinical decisions
  publication-title: HEPATOLOGY
– volume: 364
  start-page: 1207
  year: 2011
  end-page: 1217
  article-title: Boceprevir for previously treated chronic HCV genotype 1 infection
  publication-title: N Engl J Med
– volume: 361
  start-page: 580
  year: 2009
  end-page: 593
  article-title: Peginterferon alfa‐2b or alfa‐2a with ribavirin for treatment of hepatitis C infection
  publication-title: N Engl J Med
– volume: 50
  start-page: 627
  year: 2011
  end-page: 35
  article-title: Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008
  publication-title: Clin Pharmacokinet
– volume: 364
  start-page: 1195
  year: 201131
  end-page: 1206
  article-title: Boceprevir for untreated chronic HCV genotype 1 infection
  publication-title: N Engl J Med
– volume: 364
  start-page: 1195
  year: 201131
  ident: R2-10-20241201
  article-title: Boceprevir for untreated chronic HCV genotype 1 infection.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1010494
– volume: 50
  start-page: 627
  year: 2011
  ident: R8-10-20241201
  article-title: Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008.
  publication-title: Clin Pharmacokinet
  doi: 10.2165/11593210-000000000-00000
– volume: 54
  start-page: 375
  year: 2010
  ident: R7-10-20241201
  article-title: Pharmacometricsbased dose selection of levofloxacin as a treatment for postexposure inhalation anthrax in children.
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00667-09
– volume: 361
  start-page: 580
  year: 2009
  ident: R11-10-20241201
  article-title: Peginterferon alfa2b or alfa2a with ribavirin for treatment of hepatitis C infection.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0808010
– volume: 364
  start-page: 1207
  year: 2011
  ident: R3-10-20241201
  article-title: Boceprevir for previously treated chronic HCV genotype 1 infection.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1009482
– reference: 23456679 - Hepatology. 2013 Mar;57(3):875-7
SSID ssj0009428
Score 2.1621385
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 903
SubjectTerms Antiviral Agents - administration & dosage
Antiviral Agents - therapeutic use
Clinical Trials, Phase III as Topic - methods
Drug Approval - methods
Drug Monitoring - methods
Drug Resistance, Viral
Drug Therapy, Combination - standards
Evidence-Based Medicine - methods
Hepatitis C, Chronic - drug therapy
Hepatology
Humans
Interferon-alpha - therapeutic use
Proline - administration & dosage
Proline - analogs & derivatives
Proline - therapeutic use
Ribavirin - therapeutic use
United States
Title Boceprevir dosing for late responders and null responders: The role of bridging data between treatment‐naïve and ‐experienced subjects
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.25843
https://www.ncbi.nlm.nih.gov/pubmed/22610696
https://www.proquest.com/docview/1317493766
https://www.proquest.com/docview/1314708002
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2quqjYlFIoTGmRQSy6yTRxnMQuq1J1NEIqQlUrdYEU-RUhUWVGnRkWrNh30z_hI_on_RLudR5DeUiIXR52nMe9uefax8cAr9NKYZKAnmbyQkQii2N0KW6jynmrVZL6QtN855P3-fhcvLvILlbgTTcXptGH6DvcyDPC_5ocXJvZ_lI09JOfDjmGT1L6JK4WAaLTpXSUEmFdVcy6qPVUdapCMd_va96PRb8BzPt4NQSc0UP42N1qwzP5PFzMzdB-_UXF8T-fZQPWWyDKDhvLeQQrvt6EtZN2qP0xXL_FyDYNJGDmJtSjwBDfskvEpuwqEGuJAs107ViNaexPxw4Y2h4j2iKbVCzMCKPaxEVlLS2M9fz2u283tb79_sWHK-Ge77WXHZstDHUTzZ7A-ej47GgctSs3RDaVMo00V5mk3EwahGsuy6XJlJSCV7LwTptEOV0otB4hHGEWy4vECuUqKZzLtU23YLWe1P4ZsFgYqaS2khsrtPdKZVz6PMb6IpG5H8Be9w1L28qa0-oal2UjyMxLfLlleLkDeNUXnTZaHn8qtNMZQtm686xMEGUJBHJ5PoCX_Wl0RBpd0bWfLEIZUQT8PYCnjQH1rSDGxdRbYe29YAZ_b74cH38IG9v_XvQ5POBhkQ5ixu3A6vxq4XcRKs3Ni-ATPwCSVxKa
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtRAEC2FIAGXsJOBAA3ikIsndrttdyMuLIkGyEQIJVIukdWbhZTIM8rM5MCJO5f8ST6CP-FLqGovISwS4ual2-Wlyv26-_UrgGdppbCTgJFm8kJEIotjDCluo8p5q1WS-kLTeufxTj7aE-_2s_0leNGthWn0IfoBN4qM8L-mAKcB6Y1z1dBPfjrk2H6ml-AyZfQm5fw3H8_Fo5QImVWx30X2U9XpCsV8o696sTX6DWJeRKyhydm6DgfdzTZMk8PhYm6G9vMvOo7_-zQ3YKXFouxl4zw3YcnXt-DKuJ1tvw1fX2HjNg08YOYmNKjAEOKyI4Sn7Dhwa4kFzXTtWI1mfjr2nKH7MWIusknFwqIwqk10VNYyw1hPcf_-5bTW385OfLgS7vleftmx2cLQSNHsDuxtbe6-HkVt8obIplKmkeYqk9Q9kwYRm8tyaTIlpeCVLLzTJlFOFwodSAhHsMXyIrFCuUoK53Jt07uwXE9qvwosFkYqqa3kxgrtvVIZlz6Psb5IZO4HsN59xNK2yuaUYOOobDSZeYkvtwwvdwBP-6LTRs7jT4XWOk8o24ielQkCLYFYLs8H8KQ_jbFIEyy69pNFKCOKAMEHcK_xoN4KwlzsfSusvR784O_my9Hmh7Bx_9-LPoaro93xdrn9duf9A7jGQ84OIsqtwfL8eOEfInKam0chQH4An0kWtg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2iVELdUPqCaaG4VRdsMiSO49iwgsJo-gChqkgsKkV-RUigzIiZ6aKr7rvpn_AR_Em_pNfOA-hDqrrLw47zuDc-1z4-F-BVWkoMEtDTNM9ZxLI4RpeiJiqtM0omqcuVX-98cMiHx-ztSXYyB9vtWphaH6IbcPOeEf7X3sHHtty8Fg09deM-xe4zvQN3GY-lz9uw9-FaO0qykFgVwy7ffCpbWaGYbnZVb3dGvyHM24A19DiD-_CpvdeaaHLWn01133z5RcbxPx9mCRYbJEp2atN5AHOueggLB81c-yP4totd2ziwgIkd-SEFggCXnCM4JReBWes50ERVllQYx944tkXQ-IjnLZJRScKSMF_bk1FJwwsjHcH9x9fvlbq6_OzClXDPdeLLlkxm2o8TTR7D8WD_4-th1KRuiEwqRBopKjPhgzOhEa_ZjAudSSEYLUXurNKJtCqXaD6MWQ9aDM0Tw6QtBbOWK5M-gflqVLkVIDHTQgplBNWGKeekzKhwPMb6LBHc9WCj_YaFaXTNfXqN86JWZKYFvtwivNwevOyKjmsxjz8VWm0NoWj8eVIkCLMYIjnOe_CiO42e6KdXVOVGs1CG5QGA92C5NqCuFQS5GHtLrL0RzODvzRfD_aOw8fTfi67DwtHeoHj_5vDdM7hHQ8IOz5JbhfnpxcytIWya6ufBPX4CV2oVZQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Boceprevir+dosing+for+late+responders+and+null+responders%3A+the+role+of+bridging+data+between+treatment-na%C3%AFve+and+-experienced+subjects&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Florian%2C+Jeffry&rft.au=Jadhav%2C+Pravin+R&rft.au=Amur%2C+Shashi&rft.au=Ayala%2C+Ruben&rft.date=2013-03-01&rft.eissn=1527-3350&rft.volume=57&rft.issue=3&rft.spage=903&rft_id=info:doi/10.1002%2Fhep.25843&rft_id=info%3Apmid%2F22610696&rft.externalDocID=22610696
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon